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Abstract 
We report two novel macrocyclic ligands based on the 1,4-DO2AM platform (1,4-DO2AM = 2,2′-(1,4,7,10-
tetraazacyclododecane-1,4-diyl)diacetamide) and containing two benzyl groups attached either to the 
nitrogen atoms of the macrocyclic unit (1,4-BzDO2AM) or to the amide pendant arms (1,4-DO2AMBz). The 
protonation constants of the ligands and the stability constants of their Mn
2+
 complexes were determined 
using pH potentiometry. The introduction of benzyl groups results in a slight decrease of the stability 
constants of the Mn
2+
 complexes and a slight increase of their acid-catalysed dissociation reactions. A 
detailed relaxometric characterisation of the complexes using nuclear magnetic dispersion relaxation 
(NMRD) and 
17
O NMR studies indicated that the increase in molecular weight associated with the presence 
of benzyl groups results in a remarkable increase of proton relaxivities r1p, which take values of 3.8, 3.5 and 
2.5 mM
−1
 s
−1
 for [Mn(1,4-BzDO2AM)]
2+
, [Mn(1,4-DO2AMBz)]
2+
 and [Mn(1,4-DO2AM)]
2+
 (at 25 °C and 
20 MHz). The [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 complexes form relatively strong 
adducts with Human Serum Albumin (HSA) with association constants of (3.9 ± 0.6) × 10
3
 and (2.0 ± 0.3) × 
10
3
 M
−1
, respectively. The interaction with the protein slows down the rotational tumbling of the complex in 
solution, which results in adducts endowed with remarkably high proton relaxivities (r1p
b
 = 18.5 ± 0.7 and 
27.4 ± 1.4 mM
−1
 s
−1
 for [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
, respectively). 
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Introduction 
Derivatives of the tetraaza macrocycle 1,4,7,10-tetraazacyclododecane (cyclen) functionalised with different 
types and numbers of pendant arms have been investigated in detail in the last few decades due to several 
successful applications of their metal complexes.
1
 For example, lanthanide complexes of such ligands have 
proved useful as magnetic resonance imaging (MRI) contrast agents,
2
 radiopharmaceuticals for nuclear 
medicine techniques,
3
 Chemical Exchange Saturation Transfer (CEST) agents,
4
 and luminescent probes.
5
 
The tetraacetic acid derivative (DOTA) is probably the most utilised, since it forms metal complexes 
characterised by high thermodynamic stability and marked kinetic inertness towards dissociation, hence 
favouring their use in in vivo applications.
6
 
Complexes of Mn
2+
 containing coordinated water molecules have been attracting increasing attention due to 
their potential application as MRI contrast agents.
7,8
 We have recently initiated a research program to 
develop Mn
2+
 complexes that could represent an alternative to the classical Gd
3+
 MRI contrast agents.
9–12
 We 
have shown that Mn
2+
 complexes containing one or two water molecules coordinated to the metal ion present 
relaxation efficiencies comparable to those of the commercially available Gd
3+
 agents.
11
 Furthermore, we and 
others developed a family of macrocyclic and non-macrocyclic ligands containing lipophilic units that form 
micelles in solution and rather stable adducts with HSA, which results in relatively high relaxivities due to 
the elongation of the tumbling time of the complex in solution.
13–15
 Besides a potential lower toxicity of the 
Mn
2+
 complexes compared to the Gd
3+
 counterparts, redox responsive agents based on the Mn
2+
/Mn
3+
 pair 
were also proposed.
16
 
 
 
Scheme 1. Structures of the ligands discussed in this work. 
 
Macrocyclic ligands often form metal complexes with higher thermodynamic stability and kinetic inertness 
than related non-macrocyclic analogues. In the context of MRI agents, the stable complexation of the target 
metal ion is of great importance to avoid the release of the toxic free metal ion in vivo. For instance, the 
stability constants of Mn
2+
 complexes of cyclen-based ligands containing acetate pendant arms were studied 
in aqueous solution by means of potentiometric and microcalorimetric techniques, which afforded log K, 
ΔH° and TΔS° values for the complexation reactions. The metal complexes present high stability constants 
 
 
due to both favourable enthalpic and entropic contributions. With the unique exception of DOTA (1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid, Scheme 1), the entropic term is prevalent. Furthermore, it 
was also noticed that 1,4-H2DO2A (1,4,7,10-tetraazacyclododecane-1,4-diacetic acid) forms a more stable 
complex than the 1,7-H2DO2A isomer.
17,18
 The stability constant of the Mn
2+
 complex with the bis-amide 
derivative 1,4-DO2AM was found to be 2.5 log K units lower than that of [Mn(1,4-DO2A)]. However, the 
bis-amide ligand was found to be remarkably inert with respect to dissociation, with a dissociation half-life at 
pH 7.4 ca. 10 times higher than that of [Mn(1,4-DO2A)].
19
 
We envisaged expanding the family of macrocyclic Mn
2+
 complexes based on cyclen while introducing 
hydrophobic units to target HSA. Towards this aim, we present here the cyclen-based ligands 1,4-
DO2AMBz and 1,4-BzDO2AM (Scheme 1), which contain two acetamide pendants at positions 1 and 4 of 
the cyclen ring and two benzyl groups either at positions 7 and 11 of the macrocycle (1,4-BzDO2AM) or as 
N-substitution of the acetamide pendants (1,4-DO2AMBz). The presence of two hydrophobic moieties 
favours the formation of adducts with Human Serum Albumin (HSA)
20
 through non-covalent interactions. 
We report a detailed investigation of the thermodynamic stability and dissociation kinetics of the 
Mn
2+
 complexes, as well as a 
1
H and 
17
O NMR relaxometric study to determine the parameters that govern 
the relaxivity of these complexes. Finally, the interaction of the complexes with HSA was assessed using 
relaxometric techniques. 
 
 
Scheme 2. Synthesis of the ligands. (i) CH3CN, K2CO3, Δ, 24 h; (ii) diethyloxalate, EtOH, Δ, 24 h;  
(iii) benzyl bromide, CH3CN, K2CO3, Δ, 24 h; (iv) 5 M NaOH, Δ, 24 h;  
(v) N,N-dimethyl 2-chloroacetamide, CH3CN, K2CO3, Δ, 24 h. 
 
 
 
Results and discussion 
Synthesis of the ligands 
The 1,4-DO2AMBz ligand was synthesised in two steps involving the preparation of sidearm 3 by a reaction 
of 2-bromoacetyl bromide and benzyl amine,
21
 followed by the regioselective cis alkylation of 
cyclen,
22
 which provided the 1,4-DO2AMBz ligand inca. 20% yield over the two steps after semi-
preparative HPLC purification. The 1,4-BzDO2AM ligand was synthesised starting from cyclen, which was 
converted into 1,4-dibenzyl-1,4,7,10-tetraazacyclotetradecane following the method of Handel.
23
 Thus, 
cyclen was protected using diethyl oxalate to give intermediate 4 (Scheme 2), which was subsequently 
alkylated with benzyl bromide using K2CO3 as a base. Basic deprotection of compound 5 and alkylation of 
the resulting intermediate with N,N-dimethyl 2-chloroacetamide gave the 1,4-BzDO2AM ligand in a decent 
20% yield over the four steps.  
Ligand protonation constants and stability constants of the Mn
2+
 complexes 
The protonation constants of 1,4-DO2AMBz and 1,4-BzDO2AM ligands, defined in eqn (1), were 
determined by pH-potentiometry in 0.1 M KCl aqueous solution. The log Ki
H
 values are compared with those 
of 1,4-DO2AM, 1,4-DO2A
2−
, 1,7-DO2A
2−
 and DOTA
4−
 in Table 1. 
 
  𝐾𝑖
H =
[H𝑖L]
[H𝑖−1L][L]
   with 𝑖 = 1, 2, … , 6.    (1) 
 
 
Table 1. Ligand protonation constants and stability and protonation constants of the corresponding  
Mn
2+
 complexes determined using potentiometric titrations (25 °C, 0.1 M KCl) 
a 
 
 1,4-BzDO2AM 1,4-DO2AMBz 1,4-DO2AM 
b
 1,4-DO2A
2− c
 1,7-DO2A
2− c
 DOTA
4− d
 
log K1
H
 11.11(1) 9.62(3) 10.14 11.40 11.66 11.41 
log K2
H
 8.22(4) 6.90(5) 8.38 9.58 9.75 9.83 
log K3
H
 — — — 3.74 4.06 4.38 
log K4
H
 — — — 1.65 1.78 4.63 
log K5
H
 — — — — — 1.92 
log K6
H
 — — — — — 1.58 
∑log Ki
H
 19.33 16.52 18.52 26.37 27.25 33.75 
        
log 𝐾MnL 11.54(4) 10.72(3) 12.64 15.22 15.07 19.33 
log 𝐾MnLH — — — 4.15 4.09 — 
log 𝐾MnLH2  — — — — 3.70 — 
log 𝐾MnLH−1 10.44(5) 9.44(7) — — — — 
pMn 
e
 6.00 6.69 6.94 7.03 6.75 9.02 
 
a 
Standard deviations (3σ) are shown in parentheses. b Ref. 19. c Ref. 17. d Ref. 26. e Defined as −log[Mn]free with pH = 7.4, [Mn
2+
] 
= [L] = 10
−5
 M.
 
 
 
 
The protonation scheme of 1,4-DO2AM has been studied in detail using both 
1
H-NMR spectroscopy and 
pH-potentiometry methods.
19
 Because of the similarities of 1,4-BzDO2AM, 1,4-DO2AMBz and 1,4-
DO2AM, we can assume that the first protonation occurs on the nitrogen atoms of the macrocycles N1 and 
N4, which are functionalised with the acetamide pendant arms (the protonation involves partially both N-
atoms). The second protonation takes place on the unsubstituted (1,4-DO2AMBz) or benzyl-substituted (1,4-
BzDO2AM) nitrogen atom N7 (or N10) to afford a trans bis-protonated species on N1/N7 or N4/N10. The 
protonation of trans nitrogen atoms minimises the electrostatic repulsion by allowing a larger charge 
separation of the protonated sites.
24
 
Comparison of the protonation constants of 1,4-BzDO2AM and 1,4-DO2AMBz with those of 1,4-DO2AM 
indicates that the log K1
H
 value of 1,4-BzDO2AM is slightly higher, whereas the log K1
H
 and log K2
H
 values 
of 1,4-DO2AMBz are significantly lower than those of 1,4-DO2AM. The basicity of the ring N-donor atoms 
might be influenced by four factors: (i) the electron withdrawing effect of the amide groups that reduces the 
basicity of the nitrogen donor atoms; (ii) the electron donor or acceptor behaviour of the substituents on the 
amide group; (iii) the electrostatic repulsion between the protonated ring N-donor atoms resulting in a lower 
basicity of the ring amines and (iv) the formation of H-bonding interaction between the protonated nitrogen 
and the amide O-donor atoms that could increase the amine basicity.
25
 Likely, the contribution of all these 
processes is responsible for the lower log Ki
H
 values of the nitrogen donor atoms of 1,4-DO2AMBz as 
compared to 1,4-DO2AM. The total basicity (∑log Ki
H
) of 1,4-BzDO2AM is comparable to that of 1,4-
DO2AM, whereas the ∑log Ki
H
 value of 1,4-DO2AMBz is significantly lower (Table 1). 
The stability constants of the Mn
2+
 complexes of 1,4-BzDO2AM and 1,4-DO2AMBz are defined in eqn (2): 
 
  𝐾ML =
[ML]
[M][L]
       (2) 
 
The stability constants of the 1,4-BzDO2AM and 1,4-DO2AMBz complexes have been calculated from the 
titration curves obtained at 1 : 1 metal to ligand concentration ratios. The best fits of the experimental data 
(volume of KOH added vs. pH) were obtained by using the model that involves the formation of ML species 
at equilibrium. However, the titration data of the Mn
2+
-1,4-BzDO2AM and Mn
2+
-1,4-DO2AMBz systems 
indicated the consumption of base at pH > 8.5 due to the formation of hydroxide species. This process was 
characterised by the equilibrium constant KMLH−1 defined according to eqn (3): 
 
  𝐾MLH−1 =
[ML]
[MLH−1][H+]
      (3) 
 
The stability constants of the Mn
2+
 complexes formed with 1,4-BzDO2AM and 1,4-DO2AMBz are about 1 
and 2 orders of magnitude lower than that of [Mn(1,4-DO2AM)]
2+
, respectively. The lower log KML value 
determined for the [Mn(1,4-DO2AMBz)]
2+
 complex is not surprising, as the total basicity of 1,4-DO2AMBz 
is about 2 log K units lower than that of 1,4-DO2AM. However, the stability constant of the [Mn(1,4-
BzDO2AM)]
2+
 complex is significantly lower than expected by taking into account the ∑log Ki
H
 values 
presented in Table 1. Because of the similar basicity of the N donor atoms in 1,4-BzDO2AM and 1,4-
DO2AM ligands, it can be assumed that the presence of the two bulky benzyl substituents introduces some 
 
 
steric constraints for the coordination of the ligand to the relatively small Mn
2+
 ion (97 pm for coordination 
number six, high-spin configuration).
27
 
It should be noted that MnL complexes formed with 1,4-BzDO2AM, 1,4-DO2AMBz and 1,4-DO2AM 
ligands are characterised by lower stability constants than Mn(1,4-DO2A), Mn(1,7-DO2A), Mn(DO3A) and 
Mn(DOTA) complexes. The lower log KML values of the Mn
2+
-complexes formed with 1,4-DO2A-bisamide 
ligands can be explained by the lower affinity of Mn
2+
 ions to the non-charged amide oxygens with respect to 
the charged carboxylate O-donors and/or the significantly lower basicity (∑log Ki
H
) of the ring N-atoms. The 
complexes of 1,4-BzDO2AM and 1,4-DO2AMBz form hydroxo species at pH values above ca. 8.0 and 7.0, 
respectively (Fig. 1). The complexes dissociate at relatively high pH, with 2.6% of the total Mn
2+
 being in 
the form of the aqua ion at pH 6.0 for the Mn
2+
:1,4-BzDO2AM system and 22% for the Mn
2+
:1,4-
DO2AMBz system ([L] = [Mn
2+
] = 10
3
 M). Thus, the [Mn(1,4-DO2AMBz)]
2+
 complex is somewhat more 
stable about neutral pH than the [Mn(1,4-BzDO2AM)]
2+
 analogue. This is also reflected in the pMn values 
(Table 1), which provide an indication of the stability of the complex at pH 7.4. 
 
 
Fig. 1. Species distribution diagrams calculated for the 1,4-BzDO2AM:Mn
2+
 (top) and  
1,4-DO2AMBz:Mn
2+
 (bottom) systems. [L] = [Mn
2+
] = 10
−3
 M. 
 
 
Transmetallation kinetics 
Before in vivo application, it is important to evaluate the kinetic inertness of any metal-complex and thus the 
possible release of free metal ions or ligands in the body.
28
 The kinetic inertness of a metal complex is 
characterised by the rates of its dissociation, which is typically measured under strongly acidic conditions 
([H
+
] > 1.0 M).
29
 However, since these conditions differ considerably from the physiological ones, it is 
crucial to also consider the transmetallation reactions occurring with endogenous metal ions (Cu
2+
, Zn
2+
 and 
Ca
2+
) at physiological pH. In fact, a Mn
2+
 complex in body fluids may interact with these ions resulting in the 
release of the Mn
2+
-ion. Therefore, in order to assess the kinetic inertness, the rates of the transmetallation 
reactions of Mn
2+
complexes with Cu
2+
 and Zn
2+
 ions are typically determined in the pH range 2–7.18,19,26 For 
Mn
2+
 DOTA-like complexes the metal ion is slowly released through the proton-assisted dissociation 
pathway, whereas the dissociation rate is generally not altered by the presence of Zn
2+
 and Cu
2+
.
18,19,26
 For the 
direct comparison of the kinetic properties of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 with 
those of [Mn(1,4-DO2AM)]
2+
, [Mn(1,4-DO2A)], [Mn(1,7-DO2A)] and [Mn(DOTA)]
2−
, the method and the 
conditions used were the same as those previously reported.
18,19,26
 Thus, the rates of the transmetallation 
reactions of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 were determined by relaxometry at 20 
MHz and 25 °C in the pH range 4.5–6.5 using Zn2+ as the exchanging metal ion (eqn (4); L denotes either 
1,4-BzDO2AM or 1,4-DO2AMBz). 
 
  MnL + Zn2+ ⇆ ZnL + Mn2+     (4) 
 
A 10- and 20-fold excess of Zn
2+
-ions were used in order to apply a pseudo-first-order kinetic model. Then, 
the rates of the reaction can be expressed using eqn (5): 
 
  −
𝑑[MnL]𝑡
d𝑡
= 𝑘d[MnL]tot      (5) 
 
where kd is a pseudo-first-order rate constant and [MnL]t and [MnL]tot are the concentrations of the MnL 
species at time t and the total concentration of the complex, respectively. The calculated pseudo-first order 
rate constants for the transmetallation reaction of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 with 
Zn
2+
 as a function of [H
+
] are shown in Fig. 2 (see also Fig. S7–S9, ESIi). 
The rates of the transmetallation reactions are directly proportional to the H
+
 concentration and independent 
of the concentration of Zn
2+
. The increase in the kd values with increasing [H
+
] can be interpreted in terms of 
the relatively slow proton assisted dissociation of the complex, followed by a fast reaction between the free 
ligand and the exchanging Zn
2+
 ions. The dependence of kd on [H
+
] can be expressed as a first-order function 
of [H
+
] by taking into account the proton-independent (eqn (6)) and proton assisted pathways (eqn (7)), 
which are characterised by rate constants k0 and k1, respectively: 
 
  MnL
𝑘0
→ Mn2+ + L       (6) 
 
 
 
  MnL + H+
𝑘1
→ Mn2+ + HL      (7) 
 
By taking into account all possible pathways the pseudo-first-order rate constant (kd) can be expressed by the 
following linear relationship: 
 
  𝑘d = 𝑘0 + 𝑘1[H
+]       (8) 
 
The fits of the experimental kd values provided small values of k0 with large standard deviations, which 
indicates that the spontaneous dissociation pathway does not contribute significantly to the dissociation of 
the complex under the applied conditions. The k1 rate constants characterising the proton-assisted 
dissociation of the [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 complexes (Table 2) are about 4 
times higher than that of [Mn(1,4-DO2AM)]
2+
, but about three times smaller than those of the [Mn(1,4-
DO2A)] and [Mn(1,7-DO2A)] complexes. It is generally accepted that the proton assisted dissociation of 
Mn
2+
 complexes of DOTA-like ligands containing carboxylate pendant arms takes place by protonation at 
one of the carboxylate groups, which is then likely followed by proton transfer to the ring nitrogen, resulting 
in the cascade-like de-coordination of each donor atom with the release of Mn
2+
 from the coordination 
cavity.
26
 Since the replacement of the protonable carboxylate groups with non-protonable amide groups does 
not allow the formation of the protonated MnHL intermediate, it is likely that the proton assisted dissociation 
of Mn
2+
 complexes formed with DO2A-bisamides takes place by protonation of the ring N-atom followed by 
the release of the Mn
2+
 ion. By taking into account the k1 values of [Mn(1,4-BzDO2AM)]
2+
, [Mn(1,4-
DO2AMBz)]
2+
 and [Mn(1,4-DO2AM)]
2+
, it appears that the protonation of the ring N-atom in [Mn(1,4-
BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 occurs more easily, which might be explained by a weaker 
interaction between the N donor atoms of 1,4-BzDO2AM and 1,4-DO2AMBz ligands and Mn
2+
. This 
hypothesis is in line with the lower stability constants of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-
DO2AMBz)]
2+
 complexes (Table 1). The half-life (t1/2) of dissociation of [Mn(1,4-BzDO2AM)]
2+
 and 
[Mn(1,4-DO2AMBz)]
2+
 calculated for pH = 7.4 is about four times lower than that measured for [Mn(1,4-
DO2AM)]
2+
, but remains significantly longer than those reported for [Mn(1,4-DO2A)] or [Mn(1,7-DO2A)]. 
 
Table 2. Rate constants and half-lives at pH = 7.4 for the dissociation reactions of [Mn(1,4-BzDO2AM)]
2+
,  
[Mn(1,4-DO2AMBz)]
2+
and related complexes (0.1 M KCl, 25 °C) 
 
 1,4-BzDO2AM 1,4-DO2AMBz 1,4-DO2AM 
d
 1,4-DO2A
2− e
 1,7-DO2A
2− e
 DOTA
4− f
 
k0 (s
−1
) 
a a a a a 
1.8 × 10
−7
 
k1 (M
−1
 s
−1
) 36 ± 2 38 ± 2 8.7 99 84 0.04 
k2 (M
−2
 s
−1
) 
b
 — — — 1.5 × 106 2.5 × 106 1.6 × 103 
log KMnLH 
c
 — — — 4.15 4.48 4.26 
kd (s
−1
) pH = 7.4 1.4 × 10
−6
 1.5 × 10
−6
 3.5 × 10
−7
 3.9 × 10
−6
 3.3 × 10
−6
 2.6 × 10
−6
 
t1/2 (h) pH = 7.4 136 126 556 49.4 58.3 1070 
 
a 
The spontaneous dissociation of the complex characterised by k0 was found to be negligible. 
b
 k 2 rate constants characterizing the 
second-order dependence on H
+
 concentration. 
c
 Protonation constant characterising the protonated intermediate formed prior to 
complex dissociation. 
d 
Ref. 19. 
e 
Ref. 18. 
f 
Ref. 26.
 
 
 
 
 
Fig. 2. kd values obtained for the transmetallation reactions of [Mn(1,4-BzDO2AM)]
2+
 with Zn
2+
 ([MnL] = 0.5 mM, 
[Zn
2+
] = 10 mM (blue circles) and 20 mM (red triangles), 0.1 M KCl, 25 °C). 
 
 
1
H and 
17
O NMR relaxometric studies 
The r1p values of [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 as measured at 25 °C, 20 MHz and 
neutral pH are 3.8 and 3.5 mM
−1
 s
−1
, respectively. These values are considerably higher than that of [Mn(1,4-
DO2A)] and [Mn(1,4-DO2AM)]
2+
,
9,19
 suggesting that both complexes feature one coordinated water 
molecule and an enhanced inner sphere relaxivity associated with their larger size (longer τR). NMRD 
profiles were measured at 298 and 310 K over the proton Larmor frequency range 0.01–70 MHz, 
corresponding to magnetic field strengths varying between 2.343 × 10
−4
 T and 1.645 T (Fig. 3). The profiles 
have a rather simple functional form typical of low molecular weight complexes, displaying a region of 
constant relaxivity at low fields and a simple dispersion around 6–8 MHz, with a second region at high fields 
(>20 MHz) where the relaxivity tends to flatten out. The absence of a second dispersion at low fields (∼1 
MHz) indicates that the scalar contribution to relaxivity is negligible.
30
  
As for the parent [Mn(1,4-DO2AM)]
2+
 complex, relaxivity decreases by increasing temperature over the 
entire frequency range, clearly indicating that both Mn
2+
 chelates are in the fast-exchange regime and 
that r1p is only limited by the rotational correlation time. Given the relatively large number of parameters 
influencing the relaxivity of Mn
2+
 complexes, the water exchange kinetics of the coordinated water 
molecules were investigated by analysing the temperature dependence of the 
17
O NMR transverse relaxation 
rates (R2) and paramagnetic chemical shifts (Δω). The experimental data were measured using a high-
resolution NMR spectrometer, operating at 11.7 T, on aqueous solutions of the complexes (2–7 mM) at 
neutral pH. The data were then analysed according to the well-established set of Swift–Connick 
equations.
31
 The reduced R2 (1/T2r) and Δω values (Δωr) are presented in Fig. 4. The increase of 1/T2r with 
decreasing temperature over the whole temperature range investigated is a clear indication of a fast rate of 
exchange for the coordinated water molecule, in agreement with the qualitative analysis of the NMRD 
profiles recorded at different temperatures. 
 
 
 
 
Fig. 3. 
1
H NMRD profiles recorded at different temperatures for [Mn(1,4-BzDO2AM)]
2+
 (top) and [Mn(1,4-
DO2AMBz)]
2+
 (bottom). The lines represent the fits of the data as explained in the text. 
 
As for the parent [Mn(1,4-DO2AM)]
2+
 complex, relaxivity decreases by increasing temperature over the 
entire frequency range, clearly indicating that both Mn
2+
 chelates are in the fast-exchange regime and 
that r1p is only limited by the rotational correlation time. Given the relatively large number of parameters 
influencing the relaxivity of Mn
2+
 complexes, the water exchange kinetics of the coordinated water 
molecules were investigated by analysing the temperature dependence of the 
17
O NMR transverse relaxation 
rates (R2) and paramagnetic chemical shifts (Δω). The experimental data were measured using a high-
resolution NMR spectrometer, operating at 11.7 T, on aqueous solutions of the complexes (2–7 mM) at 
neutral pH. The data were then analysed according to the well-established set of Swift–Connick 
equations.
31
 The reduced R2 (1/T2r) and Δω values (Δωr) are presented in Fig. 4. The increase of 1/T2r with 
decreasing temperature over the whole temperature range investigated is a clear indication of a fast rate of 
exchange for the coordinated water molecule, in agreement with the qualitative analysis of the NMRD 
profiles recorded at different temperatures. 
 
 
 
Fig. 4. Reduced transverse 
17
O NMR relaxation rates and 
17
O NMR chemical shifts measured  
for [Mn(1,4-DO2AMBz)]
2+
 (circles) and [Mn(1,4-BzDO2AM)]
2+
 (squares) at 11.74 T.  
The lines represent the fits of the data as explained in the text. 
 
The 
1
H NMRD and 
17
O NMR data were fitted simultaneously according to the established theory of 
paramagnetic relaxation expressed by the Solomon–Bloembergen–Morgan32 and Freed33 equations for the 
inner- (IS) and outer-sphere (OS) proton relaxation mechanisms, respectively, and the Swift–Connick theory 
for 
17
O relaxation.
31
 Following a well-established practice, some parameters were fixed at reasonable values 
due to the large number of parameters that must be considered during the fitting: the hydration number q was 
fixed at 1; the distance between the metal ion and the protons of the bound water molecule, r, was fixed at 
2.83 Å; a and D were set at 3.6 Å and 2.3 × 10
−5
 cm
2
 s
−1
 (at 25 °C), respectively; EV was fixed at 1.0 kJ 
mol
−1
. The values of ER (activation energy for the rotational motion of the complex) and ED (activation 
energy of D) were fixed at those found for [Mn(1,4-DO2A)]: 19.1 and 17.3 kJ mol
−1
, respectively. The 
relevant best-fit parameters are listed in Table 3 and compared with those of related macrocyclic 
Mn
2+
 complexes. 
The electron relaxation parameters, Δ2 and τV, are very similar for both macrocyclic complexes and similar to 
the values found for the parent complex. This represents a strong indication of the occurrence of strictly 
analogous solution structures for the three complexes. The rotational correlation time τR assumes values of 
96 and 85 ps for [Mn(1,4-BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
, respectively. This nicely reflects the 
increased molecular mass of the benzyl substituted derivatives over the parent complex and confirms the 
limiting role of the rotational dynamics to the relaxivity of the complexes. In addition, the difference 
in r1p and τR values between the two chelates is well accounted for by their slightly different molecular 
masses. 
The rates of water exchange are about two times that of [Mn(1,4-DO2AM)]
2+
 and approximately half that of 
[Mn(EDTA)]
2−
. Thus, the introduction of hydrophobic substituents affects not only the rotational dynamics 
but also the water exchange dynamics of the complexes, likely by influencing the relative energy values of 
their six- and seven-coordinate states. The seven-coordinate complexes investigated here are expected to 
follow a dissociatively activated water exchange reaction proceeding through a six-coordinated transition 
 
 
state. Most likely, the presence of the benzyl groups introduces some steric hindrance around the coordinated 
water molecule, which facilitates its departure in a dissociatively activated mechanism. 
 
Table 3. Parameters obtained from the simultaneous analysis of 
17
O NMR and 
1
H NMRD data 
 
 1,4-BzDO2AM 1,4-DO2AMBz 1,4-DO2AM 
b
 1,4-DO2A
 c
 
r1p at 25/37 °C/mM
−1
 s
−1 b
 3.8/2.8 3.5/2.8 2.5/2.0 2.1/1.7 
kex
298
/10
6
 s
−1
 253 ± 9 175 ± 5 111 1134 
ΔH‡/kJ mol−1 14.4 ± 1.1 24.6 ± 0.8 39.8 29.4 
τR
298
/ps 96 ± 2 85 ± 3 53 46 
τV
298
/ps 13 ± 1 11 ± 1 5.5 4.4 
Ev/kJ mol
−1
 1.0 
a
 1.0 
a
 1.0 
a
 1.0 
a
 
Δ2/1019 s−2 20 ± 2 20 ± 1 51 48 
AO/ħ/10
6
 rad s
−1
 −31.0 ± 0.4 −33.0 ± 0.3 −39.0 −43 
rMnH/Å 2.83 
a
 2.83 
a
 2.83 
a
 2.83 
a
 
aMnH/Å 3.6 
a
 3.6 
a
 3.6 
a
 3.6 
a
 
q
298
 1 
a
 1 
a
 0.87 
a
 0.87 ª 
 
a 
Parameters fixed during the fitting procedure. 
b
 Data from Ref. 19. 
c
 Data from Ref. 9. 
 
 
DFT calculations 
DFT calculations were used to gain insight into the structure of the Mn
2+
 complexes of 1,4-BzDO2AM and 
1,4-DO2AMBz in solution. Geometry optimizations were performed on the [Mn(1,4-
BzDO2AM)(H2O)]
2+
·2H2O and [Mn(1,4-DO2AMBz)(H2O)]
2+
·2H2O systems, which contain two second-
sphere water molecules besides the water molecule directly coordinated to the metal ion. The explicit 
inclusion of two second-sphere water molecules was found to be critical for an accurate calculation of Mn–
Owater distances and 
17
O hyperfine coupling constants AO/ħ.
11,34
 Our calculations provided optimized 
geometries (Fig. 5) with coordination environments very similar to those calculated previously for [Mn(1,4-
DO2A)(H2O)],
9
 and that observed in the solid state for [Mn(1,4-DO2A)].
17
 Benzylation of the nitrogen atoms 
of the macrocycle provokes a significant lengthening of the Mn–N distances, which are significantly longer 
in the complex of 1,4-BzDO2AM compared to the 1,4-DO2AMBz derivative. The spin densities calculated 
at the nuclei of the coordinated water molecules provide AO/ħ values of −52.5 × 10
6
 and −47.3 × 106 rad 
s
−1
 for the complexes of 1,4-BzDO2AM and 1,4-DO2AMBz, respectively. The calculated values are 
somewhat higher than those determined experimentally from the analysis of the 
17
O NMR data (Table 3), but 
still similar to those reported for different Mn
2+
complexes. This could be related to the difficulties in the 
experimental determination of AO/ħ values from the observed 
17
O NMR shifts, or perhaps to the fact that our 
DFT calculations neglected dynamic effects. Alternatively, a certain fraction of q = 0 complexes in solution 
could explain the lower experimental AO/ħ data.  
 
 
 
Fig. 5. Structures of the [Mn(1,4-BzDO2AM)(H2O)]
2+
·2H2O (top) and [Mn(1,4-DO2AMBz)(H2O)]
2+
·2H2O  
(bottom) systems obtained with DFT calculations (M062X/TZVP). The bond distances of the metal  
coordination environments are given in Å. 
 
 
Human serum albumin (HSA) binding studies 
The presence of hydrophobic groups in the structure of 1,4-BzDO2AM and 1,4-DO2AMBz allows the 
complexes to bind HSA. The binding interaction has been investigated using the well-established proton 
relaxation enhancement (PRE) technique.
14
 This method consists in measuring the increase of the water 
proton longitudinal relaxation rate (R1) as a function of increasing concentration of the protein (at 20 MHz 
and 298 K in the present case, Fig. 6). R1 is enhanced by the increase of the fraction of the bound complex, 
characterized by a longer rotational correlation time. The fitting of the experimental data provides the values 
of the thermodynamic association constant, KA, the number of equivalent and independent binding sites, n, 
and the relaxivity of the resulting paramagnetic adduct, r1
bound
. All the data were fitted to 1 : 1 binding 
isotherms even though the presence of multiple affinity sites on HSA cannot be excluded for these 
complexes. The affinity of the complexes for the protein is influenced by the position of the pendant 
hydrophobic moieties, with the association constant KA obtained for [Mn(1,4-BzDO2AM)]
2+
 being ca. two 
times that obtained for [Mn(1,4-DO2AMBz)]
2+
 (Table 4). However, the relaxivity of the fully bound form is 
 
 
considerably higher for the adduct formed by [Mn(1,4-DO2AMBz)]
2+
, which indicates that the relative 
position of the benzylic groups in the two complexes influences the motional coupling between the 
paramagnetic unit and the protein. We hypothesise that the presence of the two hydrophobic groups on the 
coordinating acetamide moieties limits the degree of local motions involving the coordination cage (longer 
effective rotational correlation time) and thus increases relaxivity. The association constants obtained for the 
Mn
2+
 complexes reported here are 2–3 times higher than those reported for Gd3+complexes bearing 
analogous targeting groups.
35
 However, these anionic Gd-chelates differ from the (cationic) Mn
2+
 complexes 
reported here in their overall charges.  
 
 
Fig. 6. Changes in the observed longitudinal relaxation rates of water protons observed upon the addition  
of HSA to solutions of the [Mn(1,4-BzDO2AM)]
2+
 (0.139 mM), [Mn(1,4-DO2AMBz)]
2+
 (0.199 mM) and  
[Mn(1,4-DO2AM)]
2+
 (0.298 mM) complexes. The solid lines represent the least-squares fits of the data  
according to a 1 : 1 binding isotherm. 
 
 
Table 4. Best-fit parameters obtained from the analysis of the 
1
H relaxometric titrations (20 MHz; 298 K) of the 
Mn
2+
 complexes of 1,4-BzDO2AM, 1,4-DO2AMBz and 1,4-DO2AM with HAS 
 
 1,4-BzDO2AM 1,4-DO2AMBz 1,4-DO2AM 
n·KA (M
−1
) 3909 ± 583 1964 ± 342 1213 ± 95 
r1p
b
 (mM
−1
 s
−1
) 
a
 18.5 ± 0.7 27.4 ± 1.4 5.6 ± 0.5 
r1p
f
 (mM
−1
 s
−1
) 
b
 3.8 3.5 2.5 
 
a 
Relaxivity of the complex fully bound to the protein. 
b
 Relaxivity of the free (unbound) complex. 
 
 
A small but detectable relaxivity enhancement in the presence of HSA is observed also for [Mn(1,4-
DO2AM)]
2+
 (Fig. 6). In this case, only electrostatic forces govern the weak interaction and the binding sites 
 
 
are localized on the negatively charged domain of the protein. The limited relaxivity gain (Table 4) suggests 
either a marked decrease of the rate of water exchange or a restricted access of bulk solvent molecules to the 
paramagnetic site. Clearly, the binding sites and the mechanisms of the relaxation enhancement are quite 
different for the parent [Mn(1,4-DO2AM)]
2+
 complex and the bis-benzyl derivatives. For these latter, the 
hydrophobic interaction predominates and drives the protein binding event. 
 
Conclusions 
The chemical modification of the basic structure of 1,4-DO2AM, with the introduction of two benzyl groups 
either on the macrocycle or on the pendant arms, has a strong effect on various properties of the 
corresponding Mn
2+
 complexes. First, the complexes of the benzyl derivatives show higher r1p values. The 
increase of molecular mass appears to be translated entirely into an increase of relaxivity, thus suggesting a 
rather compact structure characterised by an isotropic tumbling motion. The high relaxivity values suggest 
the presence of one bound water molecule, although we cannot exclude the presence of a small population of 
the q = 0 isomer. In any case, the hydration state of the parent complex did not decrease upon the chemical 
modification. Second, the rate of water exchange has increased by a factor of ca. two as compared to the 
value of [Mn(1,4-DO2AM)]
2+
. This is likely related to the steric compression introduced by the benzyl 
groups around the water binding site. Third, the presence of the hydrophobic pendant groups enables the 
formation of non-covalent adducts with HSA, which are characterised by affinity constants and r1p
b
 values 
quite comparable to those typical of the analogous Gd
3+
 complexes. 
The results reported in this work also highlight the difficulties to design Mn
2+
 complexes containing a 
coordinated water molecule and possessing a high thermodynamic stability and kinetic inertness, which 
represents a challenge for coordination chemistry. The introduction of benzyl groups was found to be 
detrimental for both the thermodynamic stability and kinetic inertness. These Mn(II) chelates are cationic 
and thus not suitable for in vivo applications. Previous data on lanthanide complexes of DOTA-tetraamide 
derivatives indicated that at low doses the compounds are not easy to dissociate in vivo and are well 
tolerated.
36
 This is due to their high degree of kinetic inertness. In order for the Mn(II) complexes to be 
employed at high doses in vivo, the kinetic inertia and the incorporation of negatively charged groups are 
important requirements. 
We are currently exploring chemical modifications of these and related ligands to obtain efficient and safer 
Mn
2+
-based MRI probes. 
 
Experimental section 
General 
All chemicals were purchased from Sigma-Aldrich Co. and were used without further purification. The 
concentrations of the MnCl2 and ZnCl2 solutions were determined by complexometric titration with 
standardised Na2H2EDTA and xylenol orange (ZnCl2) or Eriochrome Black T (MnCl2) as indicators. The 
concentrations of the solutions of 1,4-BzDO2AM and 1,4-DO2AMBz were determined by pH-
potentiometric titration in the presence and absence of a 50-fold excess of CaCl2. The pH-potentiometric 
titrations were carried out with a standardised 0.2 M KOH solution. 
1
H and 
13
C NMR spectra were recorded 
on a Bruker DRX 400 (9.39 T) and a Bruker Avance III (11.74 T) spectrometers. Chemical shifts are 
reported relative to TMS and were referenced using the residual proton solvent resonances.
37
 Electrospray 
ionization mass spectra (ESI MS) were recorded on an SQD 3100 Mass Detector (Waters), operating in 
positive or negative ion mode, with 1% v/v HCOOH in methanol as the carrier solvent. HPLC analyses were 
 
 
carried out on a Waters 1525EF liquid chromatograph equipped with a Waters 2489 UV/vis and a Waters 
SQD 3100 MS detectors and using a Waters Atlantis® T3 RPC18 column (150 mm × 4.6 mm, 5 μm). 
Preparative HPLC separations were carried out using a Waters Atlantis® T3 OBD RPC18 column (100 mm 
× 19 mm, 5 μm) and a Waters FCIII fraction collector. 
Synthesis of 2,2′-(1,4,7,10-tetraazacyclododecane-1,4-diyl)bis(N-benzylacetamide) (1,4-DO2AMBz) 
2-Bromoacetyl bromide (1 mL, 11.5 mmol) and benzyl amine (1.14 mL, 10.4 mmol) were dissolved in 
CH2Cl2 (10 mL) and triethylamine (0.88 mL, 6.26 mmol) was added at 0 °C. The reaction mixture was 
stirred at 0 °C for 1 h, and then allowed to warm to room temperature. Water (15 mL) was added and the 
aqueous layer was extracted with CH2Cl2 (4 × 15 mL). The combined organic layers were washed with 5% 
HCl (50 mL), water, a saturated NaHCO3 solution (50 mL) and brine. The organic layer was dried over 
MgSO4 and then filtered. The solvent was removed under vacuum and the crude product 3 was purified by 
flash chromatography (petroleum ether : ethyl acetate 7 : 3) on silica gel. The formation of N-benzyl-2-
bromoacetamide (3)
21
was confirmed by mass spectrometry. ESI
+
/MS: m/z 228.0 ([C9H11BrNO]
+
). Cyclen 
(0.28 g, 1.6 mmol) was dissolved in acetonitrile (15 mL) and K2CO3 (0.33 g, 2.4 mmol) was added. A 
solution of compound 3 (0.74 g, 3.3 mmol) in the same solvent (20 mL) was added dropwise. The mixture 
was heated to reflux for 24 h. Then, the solution was filtered to remove the excess of carbonate, and the 
solvent was removed. The resulting aqueous solution was dried and the crude product was then purified by 
semi-preparative HPLC-MS (solvent A: H2O, TFA 0.1%; solvent B: MeOH; 0–2 min 10% B and then 
gradient 10–100% B in 18 min; flow 20 mL min−1; retention time: 6.3 min) to obtain 140 mg of an orange oil 
(0.26 mmol, 18% yield). ESI-MS (m/z): found 467.5 [M + H
+
] (calc. for C26H38N6O2: 466.5). 
1
H-NMR (D2O, 
500 MHz): δ 3.22 (σ CH2NH 4H) 3.05 (s, CH2CO, 4H), 2.85–2.65 (m, NCH2ring, 16H), 7.51–7.41 (m, 
CHAr, 10H); 
13
C-NMR (D2O, 125 MHz): δ 171.4 (C O), 131.0 (CH), 129.1 (CH), 57.7 (CH2), 53.5 (CH2), 
53.0 (CH2), 50.0 (CH2), 48.9 (CH2), 36.6 (CH2). 
Synthesis of 2,2′-(7,10-dibenzyl-1,4,7,10-tetraazacyclododecane-1,4-diyl) bis(N,N-dimethylacetamide) (1,4-
BzDO2AM) 
Cyclen (0.5 g, 2.9 mmol) was dissolved in ethanol (15 mL) and diethyl oxalate (585 μL, 4.3 mmol) was 
added dropwise. The mixture was heated to reflux for 24 h and then the solvent was removed under vacuum 
to give intermediate 1,4,7,10-tetraazabicyclo[8.2.2]tetradecane-11,12-dione (4): ESI
+
/MS: m/z 227.2 
([C10H19N4O2]
+
). Compound 4 (0.64 g, 2.8 mmol) was dissolved in acetonitrile (15 mL), and benzyl bromide 
(840 μL, 7.0 mmol) and K2CO3 (2.35 g, 17 mmol) were added to the mixture. The mixture was heated to 
reflux for 24 h and then the solvent was removed under vacuum. The crude product 4,7-dibenzyl-1,4,7,10-
tetraazabicyclo[8.2.2]tetradecane-11,12-dione (5) was dissolved in CH2Cl2 (20 mL) and washed with water 
(3 × 15 mL). The product was purified by flash chromatography (98 : 2 DCM : MeOH, silica gel). ESI-MS 
(m/z): found 407.5 [M + H
+
]. Compound 5 was dissolved in 5 M NaOH (20 mL) and the mixture was stirred 
at 100 °C for 24 h. The solution was concentrated in a rotary evaporator to a volume of 10 mL and washed 
with CH2Cl2 (3 × 20 mL). The combined organic extracts were washed with water (3 × 20 mL). The organic 
layer was dried over MgSO4 and then filtered and concentrated under vacuum. ESI-MS (m/z): found 353.5 
[M + H
+
]. The intermediate was used without any further characterization.
23
 Compound 6 (0.17 g, 0.5 mmol) 
and K2CO3 (0.63 g, 4.5 mmol) were suspended in ACN (10 ml) and N,N-dimethyl-2-chloroacetamide (105 
μL, 1.01 mmol) was added dropwise. The mixture was stirred for 24 h and then the solvent was removed in 
vacuo. The crude product 8 was purified by flash chromatography (DCM : MeOH 99 : 1, silica gel) to obtain 
a pale yellow oil (0.46 mmol, 16% yield). ESI-MS (m/z): found 523.5 [M + H
+
] (calc. for C30H46N6O2: 
522.5). 
1
H-NMR (D2O, 500 MHz): δ 4.31 (σ CH2 4H) 3.18 (s, CH2CO, 4H), 3.51 (s CH3 12H) 2.01–2.28 (m, 
NCH2 ring, 16H), 7.30–7.37 (m, CHAr, 10H); 
13
C-NMR (D2O, 125 MHz): δ 172.5 (C O), 137.8 (CH), 
126.5.0 (CH), 127.0 (CH), 127.6 (CH) 49.5 (CH2), 50.1 (CH2), 50.6 (CH2), 51.2 (CH2), 51.9 (CH2), 55.0 
(CH2) 41.9 (CH3). 
 
 
Equilibrium measurements 
The protonation constants of 1,4-BzDO2AM and 1,4-DO2AMBz, as well as the stability and protonation 
constants of the Mn
2+
complexes formed with 1,4-BzDO2AM and 1,4-DO2AMBz were determined by pH-
potentiometry. The pH-potentiometic titrations were performed at 1 : 1 metal-to-ligand concentration ratios 
(the concentration of the ligand was generally 0.002 M). For the calculation of the equilibrium constants the 
mL base–pH data were used, obtained in the pH range 1.7–12.0. For the pH measurements and titrations, a 
Metrohm 888 Titrando titration workstation and a Metrohm 6.0233.100 combined electrode were used. 
Equilibrium measurements were carried out at a constant ionic strength (0.1 M KCl) and at 25 °C in 8 mL 
samples. The solutions were stirred, and N2 was bubbled through them. KH-phthalate (pH = 4.005) and 
borax (pH = 9.177) buffers were used to calibrate the pH meter. For the calculation of [H
+
] from the 
measured pH values, the method proposed by Irving et al.was used.
38
 A 0.01 M HCl solution was titrated 
with the standardized KOH solution in the presence of 0.1 M KCl ionic strength, respectively. The 
differences between the measured (pHread) and calculated pH (−log[H
+
]) values were used to obtain the 
equilibrium H
+
 concentration from the pH values, measured in the titration experiments. The ion product of 
water was determined from the same titrations (HCl/KOH) using the data in the pH range of 11.5–12.0. 
Equilibrium constants were calculated using the PSEQUAD program.
39
 
Kinetic studies 
The kinetic inertness of the Mn
2+
 complexes was characterised by the rates of the exchange reactions taking 
place between the MnL complexes and Zn
2+
. The rates of the metal exchange reactions of [Mn(1,4-
BzDO2AM)]
2+
 and [Mn(1,4-DO2AMBz)]
2+
 with Zn
2+
 were followed by measuring the water proton 
relaxation rates (1/T1) of the samples. The kinetic measurements were performed at 0.47 T (20 MHz) and 25 
°C owing to the large differences in the relaxivities of [Mn(1,4-BzDO2AM)]
2+
 (r1p = 3.8 mM
−1
s
−1
) and 
[Mn(1,4-DO2AMBz)]
2+
 (r1p = 3.5 mM
−1
 s
−1
) and that of free Mn
2+
 (r1p = 8.0 mM
−1
 s
−1
). The longitudinal 
relaxation times were measured by the inversion recovery method (180° – τ–90°) by using 8 
different τ values. The measurements were performed with 1.0 mM [Mn(1,4-BzDO2AM)]2+ and [Mn(1,4-
DO2AMBz)]
2+
 solutions in the presence of a 10 to 20-fold excess of Zn
2+
. The temperature was maintained 
at 25 °C and the ionic strength of the solutions was kept a constant (0.1 M KCl). For keeping the pH values 
constant, N-methylpiperazine (pH range of 4.1–5.2) and piperazine (pH range of 4.7–6.6) buffers (0.01 M) 
were used. The pseudo-first-order rate constants (kd) were calculated using eqn (9): 
 
  𝑅1
𝑡 = (𝑅1
0 − 𝑅1
e)e−𝑘d𝑡 + 𝑅1
e
     (9) 
 
where R
0
1, R
t
1, and R
e
1 are the relaxation rate (1/T1) values at the start of the reaction, at time t, and at 
equilibrium, respectively. The calculations were performed using the computer program Micromath 
Scientist, version 2.0 (Salt Lake City, UT, USA). 
1
H NMRD and 
17
O NMR measurements 
The water proton longitudinal relaxation rates as a function of pH (20 MHz) were measured with a Stelar 
Spinmaster Spectrometer FFC-2000 (Mede, PV, Italy) on about 0.6–2.0 mM aqueous solutions in non-
deuterated water. The exact concentrations of Mn
2+
 ions were determined by the measurement of bulk 
magnetic susceptibility shifts of a 
t
BuOH signal on a Bruker Avance III spectrometer (11.7 
T).
40
 The 
1
H T1 relaxation times were acquired by the standard inversion recovery method with a typical 90° 
pulse width of 3.5 μs, 16 experiments of 4 scans each. The reproducibility of the T1 data was ±5%. The 
temperature was controlled with a Stelar VTC-91 airflow heater equipped with a calibrated copper-
 
 
constantan thermocouple (uncertainty of ±0.1 °C). The proton 1/T1 NMRD profiles were measured on a fast 
field-cycling Stelar SmartTracer relaxometer over a continuum of magnetic field strengths from 0.00024–
0.25 T (corresponding to 0.01–10 MHz proton Larmor frequencies). The relaxometer operates under 
computer control with an absolute uncertainty in 1/T1 of ±1%. Additional data points in the range 15–70 
MHz were obtained on a Stelar relaxometer equipped with a Bruker WP80 NMR electromagnet adapted to 
variable-field measurements (see above). 
Variable-temperature 
17
O NMR measurements were recorded on a Bruker Avance III spectrometer (11.7 T) 
equipped with a 5 mm probe and a standard temperature control unit. Aqueous solutions of the complexes (4 
mM) containing 2.0% of the 
17
O isotope (Cambridge Isotope) were used. The observed transverse relaxation 
rates were calculated from the signal width at half-height. 
DFT calculations 
Full geometry optimizations of the [Mn(1,4-DO2AMBz)(H2O)]
2+
·2H2O and [Mn(1,4-
BzDO2AM)(H2O)]
2+
·2H2O systems were performed employing DFT calculations at the M062X/TZVP
41,42
 
level with the Gaussian 09 package (revision D.01).
43
 Solvent effects were included by using the polarizable 
continuum model (PCM), in particular, the integral equation formalism (IEFPCM) variant.
44
 No symmetry 
constraints have been imposed during the optimizations. The stationary points found on the potential energy 
surfaces as a result of geometry optimizations were characterized via frequency analysis. Hyperfine coupling 
constants were calculated with the same computational approach using the EPR-III basis set of Barone for C, 
H, O and N.
45
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